“The first data on international multicenter clinical study RheoSTAT-CP0691 on the efficacy and safety of Rheosorbilact® infusion in therapy of purulent peritonitis” (2022) Perioperaciina Medicina, 5(1), pp. 34–46. doi:10.31636/prmd.v5i1.5.